Literature DB >> 16641306

Re: "combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the women's health initiative clinical trial".

Walter C Willett, JoAnn E Manson, Francine Grodstein, Meir J Stampfer, Graham A Colditz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16641306     DOI: 10.1093/aje/kwj156

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  4 in total

1.  Hormone Therapy Use and Risk of Chronic Disease in the Nurses' Health Study: A Comparative Analysis With the Women's Health Initiative.

Authors:  Shilpa N Bhupathiraju; Francine Grodstein; Bernard A Rosner; Meir J Stampfer; Frank B Hu; Walter C Willett; JoAnn E Manson
Journal:  Am J Epidemiol       Date:  2017-09-15       Impact factor: 4.897

2.  Age-specific effects of hormone therapy use on overall mortality and ischemic heart disease mortality among women in the California Teachers Study.

Authors:  Daniel O Stram; Yuan Liu; Katherine D Henderson; Jane Sullivan-Halley; Jianning Luo; Tanmai Saxena; Peggy Reynolds; Ellen T Chang; Susan L Neuhausen; Pamela L Horn-Ross; Leslie Bernstein; Giske Ursin
Journal:  Menopause       Date:  2011-03       Impact factor: 2.953

3.  Dose-dependent cardiac effect of oestrogen replacement in mice post-myocardial infarction.

Authors:  Enbo Zhan; Thomas Keimig; Jiang Xu; Edward Peterson; Jennifer Ding; Fangfei Wang; Xiao-Ping Yang
Journal:  Exp Physiol       Date:  2008-05-16       Impact factor: 2.969

4.  Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors.

Authors:  Peter Collins; Lori Mosca; Mary Jane Geiger; Deborah Grady; Marcel Kornitzer; Messan G Amewou-Atisso; Mark B Effron; Sherie A Dowsett; Elizabeth Barrett-Connor; Nanette K Wenger
Journal:  Circulation       Date:  2009-02-09       Impact factor: 29.690

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.